159 related articles for article (PubMed ID: 17436258)
1. Molecular dynamics simulations of Na+/Cl(-)-dependent neurotransmitter transporters in a membrane-aqueous system.
Jørgensen AM; Tagmose L; Jørgensen AM; Bøgesø KP; Peters GH
ChemMedChem; 2007 Jun; 2(6):827-40. PubMed ID: 17436258
[TBL] [Abstract][Full Text] [Related]
2. Y95 and E444 interaction required for high-affinity S-citalopram binding in the human serotonin transporter.
Combs S; Kaufmann K; Field JR; Blakely RD; Meiler J
ACS Chem Neurosci; 2011 Feb; 2(2):75-81. PubMed ID: 22778858
[TBL] [Abstract][Full Text] [Related]
3. Homology modeling of the serotonin transporter: insights into the primary escitalopram-binding site.
Jørgensen AM; Tagmose L; Jørgensen AM; Topiol S; Sabio M; Gundertofte K; Bøgesø KP; Peters GH
ChemMedChem; 2007 Jun; 2(6):815-26. PubMed ID: 17405130
[TBL] [Abstract][Full Text] [Related]
4. Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants.
Andersen J; Taboureau O; Hansen KB; Olsen L; Egebjerg J; Strømgaard K; Kristensen AS
J Biol Chem; 2009 Apr; 284(15):10276-84. PubMed ID: 19213730
[TBL] [Abstract][Full Text] [Related]
5. Occlusion of the human serotonin transporter is mediated by serotonin-induced conformational changes in the bundle domain.
Gradisch R; Szöllősi D; Niello M; Lazzarin E; Sitte HH; Stockner T
J Biol Chem; 2022 Mar; 298(3):101613. PubMed ID: 35065961
[TBL] [Abstract][Full Text] [Related]
6. Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers.
Rannversson H; Andersen J; Bang-Andersen B; Strømgaard K
ACS Chem Biol; 2017 Oct; 12(10):2558-2562. PubMed ID: 28910072
[TBL] [Abstract][Full Text] [Related]
7. Substrate binding and translocation of the serotonin transporter studied by docking and molecular dynamics simulations.
Gabrielsen M; Ravna AW; Kristiansen K; Sylte I
J Mol Model; 2012 Mar; 18(3):1073-85. PubMed ID: 21670993
[TBL] [Abstract][Full Text] [Related]
8. Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation.
Celik L; Sinning S; Severinsen K; Hansen CG; Møller MS; Bols M; Wiborg O; Schiøtt B
J Am Chem Soc; 2008 Mar; 130(12):3853-65. PubMed ID: 18314975
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane domain 6 of the human serotonin transporter contributes to an aqueously accessible binding pocket for serotonin and the psychostimulant 3,4-methylene dioxymethamphetamine.
Field JR; Henry LK; Blakely RD
J Biol Chem; 2010 Apr; 285(15):11270-80. PubMed ID: 20159976
[TBL] [Abstract][Full Text] [Related]
10. Computational characterization of the selective inhibition of human norepinephrine and serotonin transporters by an escitalopram scaffold.
Zheng G; Yang F; Fu T; Tu G; Chen Y; Yao X; Xue W; Zhu F
Phys Chem Chem Phys; 2018 Nov; 20(46):29513-29527. PubMed ID: 30457616
[TBL] [Abstract][Full Text] [Related]
11. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
Zhong H; Hansen KB; Boyle NJ; Han K; Muske G; Huang X; Egebjerg J; Sánchez C
Neurosci Lett; 2009 Oct; 462(3):207-12. PubMed ID: 19616061
[TBL] [Abstract][Full Text] [Related]
12. Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.
Andersen J; Olsen L; Hansen KB; Taboureau O; Jørgensen FS; Jørgensen AM; Bang-Andersen B; Egebjerg J; Strømgaard K; Kristensen AS
J Biol Chem; 2010 Jan; 285(3):2051-63. PubMed ID: 19892699
[TBL] [Abstract][Full Text] [Related]
13. Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity.
Wang CI; Lewis RJ
Biochem Pharmacol; 2010 Apr; 79(8):1083-91. PubMed ID: 19954741
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants of species-selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studies.
Kaufmann KW; Dawson ES; Henry LK; Field JR; Blakely RD; Meiler J
Proteins; 2009 Feb; 74(3):630-42. PubMed ID: 18704946
[TBL] [Abstract][Full Text] [Related]
15. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
Zhou Z; Zhen J; Karpowich NK; Goetz RM; Law CJ; Reith ME; Wang DN
Science; 2007 Sep; 317(5843):1390-3. PubMed ID: 17690258
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for action by diverse antidepressants on biogenic amine transporters.
Wang H; Goehring A; Wang KH; Penmatsa A; Ressler R; Gouaux E
Nature; 2013 Nov; 503(7474):141-5. PubMed ID: 24121440
[TBL] [Abstract][Full Text] [Related]
17. Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations.
Islas ÁA; Scior T
Molecules; 2022 May; 27(9):. PubMed ID: 35566327
[TBL] [Abstract][Full Text] [Related]
18. Substrate and Inhibitor-Specific Conformational Changes in the Human Serotonin Transporter Revealed by Voltage-Clamp Fluorometry.
Söderhielm PC; Andersen J; Munro L; Nielsen AT; Kristensen AS
Mol Pharmacol; 2015 Oct; 88(4):676-88. PubMed ID: 26174773
[TBL] [Abstract][Full Text] [Related]
19. Comparative molecular field analysis using selectivity fields reveals residues in the third transmembrane helix of the serotonin transporter associated with substrate and antagonist recognition.
Walline CC; Nichols DE; Carroll FI; Barker EL
J Pharmacol Exp Ther; 2008 Jun; 325(3):791-800. PubMed ID: 18354055
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel serotonin reuptake inhibitors targeting central and allosteric binding sites: A virtual screening and molecular dynamics simulations study.
Erol I; Aksoydan B; Kantarcioglu I; Salmas RE; Durdagi S
J Mol Graph Model; 2017 Jun; 74():193-202. PubMed ID: 28499269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
